Chorulon

Chorulon Data Sheet

Presentation
Chorulon is presented in vials as a white freeze-dried crystalline plug containing 1500 iu Chorionic Gonadotrophin together with a vial containing 5 ml solvent for reconstitution.

This product does not contain any antimicrobial preservatives.

Uses

The active ingredient of Chorulon, human Chorionic Gonadotrophin (hCG), is a complex glycoprotein with luteinising hormone (LH) activity.  In the female,  hCG can be used to promote maturation of the follicle, ovulation and the formation of the corpus luteum. In the male, Chorulon stimulates the production of testosterone and thus influences the development and maintenance of primary and secondary male sexual characteristics.

Chorulon can be used in the following fertility problems in domestic animals:

-     cases of repeated failure of conception in cows and heifers

-     induction of ovulation in mares and bitches

-     cases of cystic ovaries in cows and heifers

-     anoestrus in mares and bitches

-     delayed ovulation, prolonged pro-oestrus in bitches

-     deficiency in libido in male dogs

Dosage and administration
Reconstitute with the solvent provided, ensuring the freeze dried plug is fully dissolved. Administer by intramuscular or intravenous injection, observing the usual aseptic precautions.


Species  


Indication


Dosage and administration


Cow, heifer


Repeated failure of conception

Cystic ovarian disease (anoestrus, prolonged oestrus, nymphomania)

Enhancement of luteal function 


1500 iu- i.m. or i.v. at AI or mating


3000 iu - i.v.


1500 iu - i.m. 12 days after insemination or mating 


Mare 


Suboestrus (follicles > 2 cm in diameter)

Induction of ovulation 


1500 - 3000 iu - i.m. or i.v., repeat after 2 days if necessary

1500-3000 iu - i.m. or i.v. 24 hours before AI or mating 


Bitch 


Anoestrus




Delayed ovulation, prolonged pro-oestrus 


500 iu - i.m. or i.v. at first day of oestrus after pretreatment with PMSG 20 iu/kg s.c. daily for 10 days.

100-800 iu / day i.m., repeating treatment until vaginal bleeding disappears. Mate on behavioural oestrus 


Male dog 


Deficiency in libido 


100-500 iu - i.m. twice weekly for up to 6 weeks, but if this is not possible then 100-500 iu i.m. 6-12 hours before mating may give a temporary effect 

 

Contra-indications, warnings, etc.

In rare cases, as with all protein preparations, anaphylactoid incidents may occur shortly after injection. Adrenalin injection (1:1,000) given intravenously or intramuscularly when symptoms appear is the standard treatment. The administration of corticosteroids may also be indicated.

User warning:
Care should be taken to avoid accidental self-injection.
If accidental self -injection occurs, seek medical advice immediately and show the doctor this package leaflet.

Withdrawal periods:

Cattle: Meat/ Milk   - zero days.

Horses: Meat – zero days.

FOR ANIMAL TREATMENT ONLY.  KEEP OUT OF REACH OF CHILDREN.

Pharmaceutical precautions
Store in a refrigerator (+2oC and +8oC).  Protect from light.  Any product not used immediately after reconstitution should be stored refrigerated between +2oC and +8oC.  Reconstituted product remaining 24 hours after preparation should be discarded.

Dispose of any unused product and empty containers in accordance with guidance from your local waste regulation authority.

Legal category 
POM

Package quantities
Packs containing 5 vials supplied together with vials of solvent (each containing 5ml).

Further information
Chorulon has been used in cases of cryptorchidism in the dog prior to castration (100-500 iu i.m. twice weekly for up to 6 weeks).  Treatment may be effective in some cases provided that the inguinal canal is patent, and that therapy commences early.

Chorulon has intrinsic LH-like activity.  Injection of 1500 iu 12 days after heat in cattle enhances the active life of the corpus luteum by 2 to 3 days, resulting in increased progesterone and suppression of oestradiol production.  These changes are consistent with those observed after GnRH use at day 11-13 of the cycle which are believed to be responsible for the increased pregnancy rates seen after such use.  The mode of action is however different, since Chorulon does not rely on first stimulating an endogenous LH peak.  This use of Chorulon has not been investigated in the field.

Marketing Authorisation  number 
Vm 01708/4301

Date of preparation
February 2005

Marketing Authorisation holder
Intervet UK Ltd. 
Walton
Milton Keynes
Buckinghamshire    MK7 7AJ

Distributed in Northern Ireland by:

Intervet Ireland Ltd,

Magna Drive,

Magna Business Park,

Citywest Road,

DUBLIN24,

Ireland